Business Today
Loading...

Sun Pharma share price falls 3.5% post Q4 earnings

Stock price of Sun Pharma has fallen 1.12% in one week and 8% in one month. However, the stock has risen 4.17% since the beginning of the year.

Rupa Burman Roy Last Updated: May 27, 2020 | 18:35 IST
Sun Pharma share price falls 3.5% post Q4 earnings
Market capitalisation of Sun Pharma stock stood at Rs 1,08,099.37 crore, as of closing today

Sun Pharma share price fell almost 3.5% intraday after a volatile session on Wednesday as the pharma major posted March quarterly results today.

By the last hour of the session, Sun Pharma shares were trading 3.47% lower at the day's low of Rs 443.1 on BSE as against the last closing value of Rs 459.05. Earlier the stock opened 1.81% higher at Rs 467.40, also its day's high.

Sun Pharma stock turned volatile by the later half and closed 1.85% lower at Rs 450.55 on BSE. On NSE, the stock closed 1.95% lower at Rs 450.20.

Stock price of Sun Pharma has fallen 1.12% in one week and 8% in one month. However, the stock has risen 4.17% since the beginning of the year.

Company's stock price currently trades higher than its 50, 100 and 200 day moving averages but lower than 5 and 20-day moving averages.

Market capitalisation of Sun Pharma stock stood at Rs 1,08,099.37 crore, as of closing today.

The company reported a 37% fall in net profit at Rs 399 crore during the quarter ended March 31, 2020, as against Rs 635 crore, recorded in a year-ago period.

Company's total income rose 14% (YoY) to Rs 8,184 crore in the January-March quarter of the current fiscal as compared to Rs 7,164 crore in a year-ago period.

Sun Pharma's EBIDTA gained 34% yearly to 1,363 crore in Q4FY20 as against Rs 1,017 crore during Q4FY19.

Commenting on the results, Uday Baldota, Taro's CEO said, "Despite the leading market position of many of our products, we continue to face a challenging US generic market. In the short-term, even as we commercialise recently approved products, we expect operations and profitability to be temporarily impacted as a result of the COVID-19 pandemic."

Share Market Update: Sensex ends 995 points higher, Nifty at 9,314; Axis Bank, ICICI Bank top gainers

This Rakesh Jhunjhunwala-held stock falls 3% as firm logs zero sales in first six weeks of lockdown

PVR, Inox Leisure stocks hit by uncertainty as coronavirus brings business to halt

Sensex, Nifty turn volatile; 10 things to know about today's trend

Coronavirus India Live Updates: 6,387 cases 170 deaths in 24 hours takes India's COVID-19 tally past 1.5 lakh

Stocks in news: Torrent Pharma, Blue Dart, Sun Pharma, Dabur, United Spirits, Bharti Airtel, VIP Industries among others

Youtube
  • Print

  • COMMENT
BT-Story-Page-B.gif
A    A   A
close